Emily Kopp, Web Producer at Kaiser Health News, most recently worked as a freelance reporter. She has previously worked at Politico and AIS Health. Before that, she interned with the Center for Responsive Politics.
Emily Kopp
From this contributor
Nonprofit with ties to pharma launches campaign against drug imports
Both the Pharmaceutical Research and Manufacturers of America and the nonprofit group have gone to great lengths to show that drugmakers are not driving what they describe as a “grass-roots” effort to fight imports.
Nonprofit with ties to pharma launches campaign against drug imports
By
Emily Kopp, Rachel Bluth, Kaiser Health News
20 April 2017 | 8 min read
Senators want answers about reported probe of U.S. health secretary
Nine U.S. senators are pushing the U.S. Attorney General to reveal what he knows about a reported investigation into Tom Price’s stock trades that a top federal prosecutor might have begun before being fired by the Trump administration.
Senators want answers about reported probe of U.S. health secretary
By
Emily Kopp, Rachel Bluth, Kaiser Health News
31 March 2017 | 4 min read
Most patient advocacy groups accept funding from pharma
At least 83 percent of the United States' largest patient advocacy groups take contributions from the drug industry, and not all of them are transparent about it.
Most patient advocacy groups accept funding from pharma
By
Emily Kopp, Kaiser Health News
2 March 2017 | 5 min read
Explore more from The Transmitter
By
Claudia López Lloreda, Calli McMurray, Natalia Mesa, Madeline Shaw
5 October 2026
11 min read
How Nobel Prize-winning optogenetics has revolutionized neuroscience
The technique has enabled neuroscientists to target brain circuits and cells with unprecedented specificity, transforming the study of memory, interoception, brain disorders and reward, among other domains.
How Nobel Prize-winning optogenetics has revolutionized neuroscience
The technique has enabled neuroscientists to target brain circuits and cells with unprecedented specificity, transforming the study of memory, interoception, brain disorders and reward, among other domains.
By
Claudia López Lloreda, Calli McMurray, Natalia Mesa, Madeline Shaw
5 October 2026 | 11 min read
Is confidence a second thought—or part of the first one?
In some settings, neural circuits may calculate confidence in a decision simultaneously with the choice itself. That changes the types of questions researchers should ask.
Is confidence a second thought—or part of the first one?
In some settings, neural circuits may calculate confidence in a decision simultaneously with the choice itself. That changes the types of questions researchers should ask.
By
Ariel Zylberberg
5 October 2026 | 6 min read
What AI can learn from hunger
To enhance AI safety, take a lesson from biological brains; a small set of wants maintains durable control over a much larger cognitive system.
What AI can learn from hunger
To enhance AI safety, take a lesson from biological brains; a small set of wants maintains durable control over a much larger cognitive system.
By
Anthony Zador
5 October 2026 | 6 min read